CollPlant Biotechnologies (CLGN) Inventory Average (2018 - 2024)

CollPlant Biotechnologies' Inventory Average history runs 7 years deep, the most recent figure standing at $447.0 million for Q4 2024.

• Quarterly Inventory Average fell 40.55% year-over-year to $447.0 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $447.0 million (down 40.55% YoY) and the FY2025 annual result came in at $220.3 million, changed 0.03% from the prior year.
• Inventory Average was $447.0 million for Q4 2024 at CollPlant Biotechnologies, up from $227.2 million in the prior quarter.
• Across five years, Inventory Average topped out at $540.5 billion in Q1 2022 and bottomed at $848500.0 in Q3 2020.
• A 5-year average of $54.3 billion and a median of $383.7 million in 2020 frame the typical range for Inventory Average.
• Annual changes were most pronounced in 2021 — Inventory Average jumped 48497035.62% — and 2022, when it tumbled 99.87%.
• CollPlant Biotechnologies' Inventory Average stood at $1.1 million in 2020, then soared by 48497035.62% to $540.5 billion in 2021, then tumbled by 99.87% to $715.6 million in 2022, then increased by 5.07% to $751.9 million in 2023, then slumped by 40.55% to $447.0 million in 2024.
• Business Quant data shows CLGN's Inventory Average at $447.0 million in Q4 2024, $227.2 million in Q3 2024, and $322.7 million in Q2 2024.